nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—HTR2C—Sorafenib—thyroid cancer	0.139	0.386	CbGbCtD
Paliperidone—CYP3A5—Sorafenib—thyroid cancer	0.0679	0.188	CbGbCtD
Paliperidone—CYP3A4—Vandetanib—thyroid cancer	0.0439	0.122	CbGbCtD
Paliperidone—CYP2D6—Sorafenib—thyroid cancer	0.0416	0.116	CbGbCtD
Paliperidone—CYP3A4—Sorafenib—thyroid cancer	0.0265	0.0735	CbGbCtD
Paliperidone—CYP2D6—Doxorubicin—thyroid cancer	0.0253	0.0701	CbGbCtD
Paliperidone—CYP3A4—Doxorubicin—thyroid cancer	0.0161	0.0446	CbGbCtD
Paliperidone—Abdominal pain—Sorafenib—thyroid cancer	0.000596	0.00105	CcSEcCtD
Paliperidone—Body temperature increased—Sorafenib—thyroid cancer	0.000596	0.00105	CcSEcCtD
Paliperidone—Eczema—Doxorubicin—thyroid cancer	0.000584	0.00103	CcSEcCtD
Paliperidone—Hypoglycaemia—Epirubicin—thyroid cancer	0.000581	0.00102	CcSEcCtD
Paliperidone—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000578	0.00102	CcSEcCtD
Paliperidone—Lethargy—Epirubicin—thyroid cancer	0.000578	0.00102	CcSEcCtD
Paliperidone—Pain in extremity—Epirubicin—thyroid cancer	0.000567	0.000996	CcSEcCtD
Paliperidone—Osteoarthritis—Epirubicin—thyroid cancer	0.000567	0.000996	CcSEcCtD
Paliperidone—Increased appetite—Doxorubicin—thyroid cancer	0.000558	0.000981	CcSEcCtD
Paliperidone—Hypersensitivity—Sorafenib—thyroid cancer	0.000555	0.000976	CcSEcCtD
Paliperidone—Face oedema—Epirubicin—thyroid cancer	0.000547	0.000961	CcSEcCtD
Paliperidone—Asthenia—Sorafenib—thyroid cancer	0.000541	0.00095	CcSEcCtD
Paliperidone—Cardiac arrest—Epirubicin—thyroid cancer	0.000539	0.000947	CcSEcCtD
Paliperidone—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000537	0.000944	CcSEcCtD
Paliperidone—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000535	0.00094	CcSEcCtD
Paliperidone—Lethargy—Doxorubicin—thyroid cancer	0.000535	0.00094	CcSEcCtD
Paliperidone—Pruritus—Sorafenib—thyroid cancer	0.000533	0.000937	CcSEcCtD
Paliperidone—Osteoarthritis—Doxorubicin—thyroid cancer	0.000524	0.000921	CcSEcCtD
Paliperidone—Pain in extremity—Doxorubicin—thyroid cancer	0.000524	0.000921	CcSEcCtD
Paliperidone—Dry skin—Epirubicin—thyroid cancer	0.00052	0.000913	CcSEcCtD
Paliperidone—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000518	0.000909	CcSEcCtD
Paliperidone—Abdominal pain upper—Epirubicin—thyroid cancer	0.000518	0.000909	CcSEcCtD
Paliperidone—Diarrhoea—Sorafenib—thyroid cancer	0.000516	0.000906	CcSEcCtD
Paliperidone—Breast disorder—Epirubicin—thyroid cancer	0.000512	0.0009	CcSEcCtD
Paliperidone—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00051	0.000897	CcSEcCtD
Paliperidone—Nasopharyngitis—Epirubicin—thyroid cancer	0.000507	0.00089	CcSEcCtD
Paliperidone—Face oedema—Doxorubicin—thyroid cancer	0.000506	0.000889	CcSEcCtD
Paliperidone—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.0005	0.000878	CcSEcCtD
Paliperidone—Muscular weakness—Epirubicin—thyroid cancer	0.0005	0.000878	CcSEcCtD
Paliperidone—Cardiac arrest—Doxorubicin—thyroid cancer	0.000499	0.000876	CcSEcCtD
Paliperidone—Dizziness—Sorafenib—thyroid cancer	0.000498	0.000876	CcSEcCtD
Paliperidone—Influenza—Epirubicin—thyroid cancer	0.00049	0.000861	CcSEcCtD
Paliperidone—Dysphagia—Epirubicin—thyroid cancer	0.00049	0.000861	CcSEcCtD
Paliperidone—Dry skin—Doxorubicin—thyroid cancer	0.000481	0.000844	CcSEcCtD
Paliperidone—Pancreatitis—Epirubicin—thyroid cancer	0.00048	0.000844	CcSEcCtD
Paliperidone—Vomiting—Sorafenib—thyroid cancer	0.000479	0.000842	CcSEcCtD
Paliperidone—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000479	0.000841	CcSEcCtD
Paliperidone—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000479	0.000841	CcSEcCtD
Paliperidone—Rash—Sorafenib—thyroid cancer	0.000475	0.000835	CcSEcCtD
Paliperidone—Dermatitis—Sorafenib—thyroid cancer	0.000475	0.000834	CcSEcCtD
Paliperidone—Breast disorder—Doxorubicin—thyroid cancer	0.000474	0.000833	CcSEcCtD
Paliperidone—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000472	0.00083	CcSEcCtD
Paliperidone—Headache—Sorafenib—thyroid cancer	0.000472	0.00083	CcSEcCtD
Paliperidone—Bronchitis—Epirubicin—thyroid cancer	0.000471	0.000828	CcSEcCtD
Paliperidone—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000469	0.000824	CcSEcCtD
Paliperidone—Muscular weakness—Doxorubicin—thyroid cancer	0.000463	0.000813	CcSEcCtD
Paliperidone—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000463	0.000813	CcSEcCtD
Paliperidone—Dysuria—Epirubicin—thyroid cancer	0.000458	0.000805	CcSEcCtD
Paliperidone—Neutropenia—Epirubicin—thyroid cancer	0.000458	0.000805	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000455	0.0008	CcSEcCtD
Paliperidone—Dysphagia—Doxorubicin—thyroid cancer	0.000453	0.000796	CcSEcCtD
Paliperidone—Influenza—Doxorubicin—thyroid cancer	0.000453	0.000796	CcSEcCtD
Paliperidone—Pollakiuria—Epirubicin—thyroid cancer	0.000453	0.000795	CcSEcCtD
Paliperidone—Nausea—Sorafenib—thyroid cancer	0.000448	0.000787	CcSEcCtD
Paliperidone—Weight increased—Epirubicin—thyroid cancer	0.000446	0.000783	CcSEcCtD
Paliperidone—Pancreatitis—Doxorubicin—thyroid cancer	0.000444	0.000781	CcSEcCtD
Paliperidone—Weight decreased—Epirubicin—thyroid cancer	0.000443	0.000779	CcSEcCtD
Paliperidone—Hyperglycaemia—Epirubicin—thyroid cancer	0.000442	0.000776	CcSEcCtD
Paliperidone—Pneumonia—Epirubicin—thyroid cancer	0.000439	0.000772	CcSEcCtD
Paliperidone—Infestation NOS—Epirubicin—thyroid cancer	0.000437	0.000767	CcSEcCtD
Paliperidone—Infestation—Epirubicin—thyroid cancer	0.000437	0.000767	CcSEcCtD
Paliperidone—Bronchitis—Doxorubicin—thyroid cancer	0.000436	0.000766	CcSEcCtD
Paliperidone—Jaundice—Epirubicin—thyroid cancer	0.000426	0.000748	CcSEcCtD
Paliperidone—Urinary tract infection—Epirubicin—thyroid cancer	0.000425	0.000746	CcSEcCtD
Paliperidone—Conjunctivitis—Epirubicin—thyroid cancer	0.000425	0.000746	CcSEcCtD
Paliperidone—Dysuria—Doxorubicin—thyroid cancer	0.000424	0.000745	CcSEcCtD
Paliperidone—Neutropenia—Doxorubicin—thyroid cancer	0.000424	0.000745	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000421	0.00074	CcSEcCtD
Paliperidone—Pollakiuria—Doxorubicin—thyroid cancer	0.000419	0.000736	CcSEcCtD
Paliperidone—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000413	0.000726	CcSEcCtD
Paliperidone—Weight increased—Doxorubicin—thyroid cancer	0.000412	0.000725	CcSEcCtD
Paliperidone—Epistaxis—Epirubicin—thyroid cancer	0.000412	0.000724	CcSEcCtD
Paliperidone—Weight decreased—Doxorubicin—thyroid cancer	0.00041	0.00072	CcSEcCtD
Paliperidone—Sinusitis—Epirubicin—thyroid cancer	0.00041	0.00072	CcSEcCtD
Paliperidone—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000409	0.000718	CcSEcCtD
Paliperidone—Agranulocytosis—Epirubicin—thyroid cancer	0.000408	0.000716	CcSEcCtD
Paliperidone—Pneumonia—Doxorubicin—thyroid cancer	0.000406	0.000714	CcSEcCtD
Paliperidone—Infestation NOS—Doxorubicin—thyroid cancer	0.000404	0.00071	CcSEcCtD
Paliperidone—Infestation—Doxorubicin—thyroid cancer	0.000404	0.00071	CcSEcCtD
Paliperidone—Bradycardia—Epirubicin—thyroid cancer	0.000399	0.000701	CcSEcCtD
Paliperidone—Jaundice—Doxorubicin—thyroid cancer	0.000394	0.000692	CcSEcCtD
Paliperidone—Rhinitis—Epirubicin—thyroid cancer	0.000393	0.000691	CcSEcCtD
Paliperidone—Conjunctivitis—Doxorubicin—thyroid cancer	0.000393	0.00069	CcSEcCtD
Paliperidone—Urinary tract infection—Doxorubicin—thyroid cancer	0.000393	0.00069	CcSEcCtD
Paliperidone—Hypoaesthesia—Epirubicin—thyroid cancer	0.00039	0.000685	CcSEcCtD
Paliperidone—Urinary tract disorder—Epirubicin—thyroid cancer	0.000387	0.00068	CcSEcCtD
Paliperidone—Oedema peripheral—Epirubicin—thyroid cancer	0.000386	0.000679	CcSEcCtD
Paliperidone—Connective tissue disorder—Epirubicin—thyroid cancer	0.000385	0.000677	CcSEcCtD
Paliperidone—Urethral disorder—Epirubicin—thyroid cancer	0.000384	0.000675	CcSEcCtD
Paliperidone—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000382	0.000671	CcSEcCtD
Paliperidone—Epistaxis—Doxorubicin—thyroid cancer	0.000381	0.00067	CcSEcCtD
Paliperidone—Sinusitis—Doxorubicin—thyroid cancer	0.000379	0.000666	CcSEcCtD
Paliperidone—Agranulocytosis—Doxorubicin—thyroid cancer	0.000377	0.000663	CcSEcCtD
Paliperidone—Bradycardia—Doxorubicin—thyroid cancer	0.000369	0.000649	CcSEcCtD
Paliperidone—Eye disorder—Epirubicin—thyroid cancer	0.000366	0.000644	CcSEcCtD
Paliperidone—Tinnitus—Epirubicin—thyroid cancer	0.000366	0.000642	CcSEcCtD
Paliperidone—Cardiac disorder—Epirubicin—thyroid cancer	0.000364	0.000639	CcSEcCtD
Paliperidone—Flushing—Epirubicin—thyroid cancer	0.000364	0.000639	CcSEcCtD
Paliperidone—Rhinitis—Doxorubicin—thyroid cancer	0.000364	0.000639	CcSEcCtD
Paliperidone—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000361	0.000634	CcSEcCtD
Paliperidone—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000358	0.000629	CcSEcCtD
Paliperidone—Oedema peripheral—Doxorubicin—thyroid cancer	0.000357	0.000628	CcSEcCtD
Paliperidone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000357	0.000626	CcSEcCtD
Paliperidone—Angiopathy—Epirubicin—thyroid cancer	0.000356	0.000625	CcSEcCtD
Paliperidone—Urethral disorder—Doxorubicin—thyroid cancer	0.000356	0.000625	CcSEcCtD
Paliperidone—Immune system disorder—Epirubicin—thyroid cancer	0.000354	0.000622	CcSEcCtD
Paliperidone—Mediastinal disorder—Epirubicin—thyroid cancer	0.000353	0.000621	CcSEcCtD
Paliperidone—Chills—Epirubicin—thyroid cancer	0.000352	0.000618	CcSEcCtD
Paliperidone—Alopecia—Epirubicin—thyroid cancer	0.000346	0.000609	CcSEcCtD
Paliperidone—Mental disorder—Epirubicin—thyroid cancer	0.000344	0.000603	CcSEcCtD
Paliperidone—Malnutrition—Epirubicin—thyroid cancer	0.000341	0.0006	CcSEcCtD
Paliperidone—Erythema—Epirubicin—thyroid cancer	0.000341	0.0006	CcSEcCtD
Paliperidone—Eye disorder—Doxorubicin—thyroid cancer	0.000339	0.000596	CcSEcCtD
Paliperidone—Tinnitus—Doxorubicin—thyroid cancer	0.000338	0.000594	CcSEcCtD
Paliperidone—Flushing—Doxorubicin—thyroid cancer	0.000337	0.000591	CcSEcCtD
Paliperidone—Cardiac disorder—Doxorubicin—thyroid cancer	0.000337	0.000591	CcSEcCtD
Paliperidone—Flatulence—Epirubicin—thyroid cancer	0.000336	0.000591	CcSEcCtD
Paliperidone—Tension—Epirubicin—thyroid cancer	0.000335	0.000588	CcSEcCtD
Paliperidone—Dysgeusia—Epirubicin—thyroid cancer	0.000334	0.000587	CcSEcCtD
Paliperidone—Nervousness—Epirubicin—thyroid cancer	0.000332	0.000582	CcSEcCtD
Paliperidone—Back pain—Epirubicin—thyroid cancer	0.00033	0.00058	CcSEcCtD
Paliperidone—Angiopathy—Doxorubicin—thyroid cancer	0.000329	0.000578	CcSEcCtD
Paliperidone—Muscle spasms—Epirubicin—thyroid cancer	0.000328	0.000576	CcSEcCtD
Paliperidone—Immune system disorder—Doxorubicin—thyroid cancer	0.000328	0.000576	CcSEcCtD
Paliperidone—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000327	0.000574	CcSEcCtD
Paliperidone—Chills—Doxorubicin—thyroid cancer	0.000326	0.000572	CcSEcCtD
Paliperidone—Vision blurred—Epirubicin—thyroid cancer	0.000322	0.000565	CcSEcCtD
Paliperidone—Alopecia—Doxorubicin—thyroid cancer	0.000321	0.000563	CcSEcCtD
Paliperidone—Mental disorder—Doxorubicin—thyroid cancer	0.000318	0.000558	CcSEcCtD
Paliperidone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000317	0.000556	CcSEcCtD
Paliperidone—Erythema—Doxorubicin—thyroid cancer	0.000316	0.000555	CcSEcCtD
Paliperidone—Malnutrition—Doxorubicin—thyroid cancer	0.000316	0.000555	CcSEcCtD
Paliperidone—Anaemia—Epirubicin—thyroid cancer	0.000315	0.000554	CcSEcCtD
Paliperidone—Agitation—Epirubicin—thyroid cancer	0.000314	0.000551	CcSEcCtD
Paliperidone—Flatulence—Doxorubicin—thyroid cancer	0.000311	0.000547	CcSEcCtD
Paliperidone—Tension—Doxorubicin—thyroid cancer	0.00031	0.000544	CcSEcCtD
Paliperidone—Dysgeusia—Doxorubicin—thyroid cancer	0.000309	0.000543	CcSEcCtD
Paliperidone—Malaise—Epirubicin—thyroid cancer	0.000308	0.000541	CcSEcCtD
Paliperidone—Nervousness—Doxorubicin—thyroid cancer	0.000307	0.000539	CcSEcCtD
Paliperidone—Vertigo—Epirubicin—thyroid cancer	0.000307	0.000539	CcSEcCtD
Paliperidone—Syncope—Epirubicin—thyroid cancer	0.000306	0.000538	CcSEcCtD
Paliperidone—Leukopenia—Epirubicin—thyroid cancer	0.000306	0.000537	CcSEcCtD
Paliperidone—Back pain—Doxorubicin—thyroid cancer	0.000305	0.000537	CcSEcCtD
Paliperidone—Muscle spasms—Doxorubicin—thyroid cancer	0.000304	0.000533	CcSEcCtD
Paliperidone—Palpitations—Epirubicin—thyroid cancer	0.000302	0.00053	CcSEcCtD
Paliperidone—Loss of consciousness—Epirubicin—thyroid cancer	0.0003	0.000527	CcSEcCtD
Paliperidone—Cough—Epirubicin—thyroid cancer	0.000298	0.000523	CcSEcCtD
Paliperidone—Vision blurred—Doxorubicin—thyroid cancer	0.000298	0.000523	CcSEcCtD
Paliperidone—Convulsion—Epirubicin—thyroid cancer	0.000296	0.00052	CcSEcCtD
Paliperidone—Hypertension—Epirubicin—thyroid cancer	0.000295	0.000518	CcSEcCtD
Paliperidone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000293	0.000515	CcSEcCtD
Paliperidone—Anaemia—Doxorubicin—thyroid cancer	0.000292	0.000513	CcSEcCtD
Paliperidone—Arthralgia—Epirubicin—thyroid cancer	0.000291	0.00051	CcSEcCtD
Paliperidone—Chest pain—Epirubicin—thyroid cancer	0.000291	0.00051	CcSEcCtD
Paliperidone—Myalgia—Epirubicin—thyroid cancer	0.000291	0.00051	CcSEcCtD
Paliperidone—Agitation—Doxorubicin—thyroid cancer	0.00029	0.00051	CcSEcCtD
Paliperidone—Anxiety—Epirubicin—thyroid cancer	0.00029	0.000509	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000289	0.000507	CcSEcCtD
Paliperidone—Discomfort—Epirubicin—thyroid cancer	0.000287	0.000504	CcSEcCtD
Paliperidone—Malaise—Doxorubicin—thyroid cancer	0.000285	0.0005	CcSEcCtD
Paliperidone—Dry mouth—Epirubicin—thyroid cancer	0.000284	0.000499	CcSEcCtD
Paliperidone—Vertigo—Doxorubicin—thyroid cancer	0.000284	0.000498	CcSEcCtD
Paliperidone—Syncope—Doxorubicin—thyroid cancer	0.000283	0.000498	CcSEcCtD
Paliperidone—Leukopenia—Doxorubicin—thyroid cancer	0.000283	0.000497	CcSEcCtD
Paliperidone—Confusional state—Epirubicin—thyroid cancer	0.000281	0.000493	CcSEcCtD
Paliperidone—Palpitations—Doxorubicin—thyroid cancer	0.000279	0.00049	CcSEcCtD
Paliperidone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000279	0.000489	CcSEcCtD
Paliperidone—Oedema—Epirubicin—thyroid cancer	0.000279	0.000489	CcSEcCtD
Paliperidone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000278	0.000488	CcSEcCtD
Paliperidone—Infection—Epirubicin—thyroid cancer	0.000277	0.000486	CcSEcCtD
Paliperidone—Cough—Doxorubicin—thyroid cancer	0.000276	0.000484	CcSEcCtD
Paliperidone—Shock—Epirubicin—thyroid cancer	0.000274	0.000481	CcSEcCtD
Paliperidone—Convulsion—Doxorubicin—thyroid cancer	0.000274	0.000481	CcSEcCtD
Paliperidone—Nervous system disorder—Epirubicin—thyroid cancer	0.000273	0.00048	CcSEcCtD
Paliperidone—Thrombocytopenia—Epirubicin—thyroid cancer	0.000273	0.000479	CcSEcCtD
Paliperidone—Hypertension—Doxorubicin—thyroid cancer	0.000273	0.000479	CcSEcCtD
Paliperidone—Tachycardia—Epirubicin—thyroid cancer	0.000272	0.000478	CcSEcCtD
Paliperidone—Skin disorder—Epirubicin—thyroid cancer	0.000271	0.000475	CcSEcCtD
Paliperidone—Arthralgia—Doxorubicin—thyroid cancer	0.000269	0.000472	CcSEcCtD
Paliperidone—Myalgia—Doxorubicin—thyroid cancer	0.000269	0.000472	CcSEcCtD
Paliperidone—Chest pain—Doxorubicin—thyroid cancer	0.000269	0.000472	CcSEcCtD
Paliperidone—Anxiety—Doxorubicin—thyroid cancer	0.000268	0.000471	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000267	0.000469	CcSEcCtD
Paliperidone—Discomfort—Doxorubicin—thyroid cancer	0.000266	0.000467	CcSEcCtD
Paliperidone—Anorexia—Epirubicin—thyroid cancer	0.000266	0.000466	CcSEcCtD
Paliperidone—Dry mouth—Doxorubicin—thyroid cancer	0.000263	0.000462	CcSEcCtD
Paliperidone—Hypotension—Epirubicin—thyroid cancer	0.00026	0.000457	CcSEcCtD
Paliperidone—Confusional state—Doxorubicin—thyroid cancer	0.00026	0.000457	CcSEcCtD
Paliperidone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000258	0.000453	CcSEcCtD
Paliperidone—Oedema—Doxorubicin—thyroid cancer	0.000258	0.000453	CcSEcCtD
Paliperidone—Infection—Doxorubicin—thyroid cancer	0.000256	0.00045	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000254	0.000446	CcSEcCtD
Paliperidone—Shock—Doxorubicin—thyroid cancer	0.000254	0.000445	CcSEcCtD
Paliperidone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000253	0.000444	CcSEcCtD
Paliperidone—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000252	0.000443	CcSEcCtD
Paliperidone—Insomnia—Epirubicin—thyroid cancer	0.000252	0.000443	CcSEcCtD
Paliperidone—Tachycardia—Doxorubicin—thyroid cancer	0.000252	0.000442	CcSEcCtD
Paliperidone—Skin disorder—Doxorubicin—thyroid cancer	0.00025	0.00044	CcSEcCtD
Paliperidone—Paraesthesia—Epirubicin—thyroid cancer	0.00025	0.000439	CcSEcCtD
Paliperidone—Dyspnoea—Epirubicin—thyroid cancer	0.000248	0.000436	CcSEcCtD
Paliperidone—Somnolence—Epirubicin—thyroid cancer	0.000248	0.000435	CcSEcCtD
Paliperidone—Anorexia—Doxorubicin—thyroid cancer	0.000246	0.000432	CcSEcCtD
Paliperidone—Dyspepsia—Epirubicin—thyroid cancer	0.000245	0.000431	CcSEcCtD
Paliperidone—Decreased appetite—Epirubicin—thyroid cancer	0.000242	0.000425	CcSEcCtD
Paliperidone—Hypotension—Doxorubicin—thyroid cancer	0.000241	0.000423	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00024	0.000422	CcSEcCtD
Paliperidone—Fatigue—Epirubicin—thyroid cancer	0.00024	0.000422	CcSEcCtD
Paliperidone—Pain—Epirubicin—thyroid cancer	0.000238	0.000418	CcSEcCtD
Paliperidone—Constipation—Epirubicin—thyroid cancer	0.000238	0.000418	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000235	0.000413	CcSEcCtD
Paliperidone—Insomnia—Doxorubicin—thyroid cancer	0.000233	0.00041	CcSEcCtD
Paliperidone—Paraesthesia—Doxorubicin—thyroid cancer	0.000231	0.000407	CcSEcCtD
Paliperidone—Dyspnoea—Doxorubicin—thyroid cancer	0.00023	0.000404	CcSEcCtD
Paliperidone—Feeling abnormal—Epirubicin—thyroid cancer	0.00023	0.000403	CcSEcCtD
Paliperidone—Somnolence—Doxorubicin—thyroid cancer	0.000229	0.000403	CcSEcCtD
Paliperidone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000228	0.0004	CcSEcCtD
Paliperidone—Dyspepsia—Doxorubicin—thyroid cancer	0.000227	0.000399	CcSEcCtD
Paliperidone—Decreased appetite—Doxorubicin—thyroid cancer	0.000224	0.000394	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000223	0.000391	CcSEcCtD
Paliperidone—Fatigue—Doxorubicin—thyroid cancer	0.000222	0.00039	CcSEcCtD
Paliperidone—Urticaria—Epirubicin—thyroid cancer	0.000221	0.000389	CcSEcCtD
Paliperidone—Pain—Doxorubicin—thyroid cancer	0.00022	0.000387	CcSEcCtD
Paliperidone—Constipation—Doxorubicin—thyroid cancer	0.00022	0.000387	CcSEcCtD
Paliperidone—Abdominal pain—Epirubicin—thyroid cancer	0.00022	0.000387	CcSEcCtD
Paliperidone—Body temperature increased—Epirubicin—thyroid cancer	0.00022	0.000387	CcSEcCtD
Paliperidone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000212	0.000373	CcSEcCtD
Paliperidone—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000211	0.00037	CcSEcCtD
Paliperidone—Hypersensitivity—Epirubicin—thyroid cancer	0.000205	0.000361	CcSEcCtD
Paliperidone—Urticaria—Doxorubicin—thyroid cancer	0.000205	0.00036	CcSEcCtD
Paliperidone—Abdominal pain—Doxorubicin—thyroid cancer	0.000204	0.000358	CcSEcCtD
Paliperidone—Body temperature increased—Doxorubicin—thyroid cancer	0.000204	0.000358	CcSEcCtD
Paliperidone—Asthenia—Epirubicin—thyroid cancer	0.0002	0.000351	CcSEcCtD
Paliperidone—Pruritus—Epirubicin—thyroid cancer	0.000197	0.000346	CcSEcCtD
Paliperidone—Diarrhoea—Epirubicin—thyroid cancer	0.000191	0.000335	CcSEcCtD
Paliperidone—Hypersensitivity—Doxorubicin—thyroid cancer	0.00019	0.000334	CcSEcCtD
Paliperidone—Asthenia—Doxorubicin—thyroid cancer	0.000185	0.000325	CcSEcCtD
Paliperidone—Dizziness—Epirubicin—thyroid cancer	0.000184	0.000324	CcSEcCtD
Paliperidone—Pruritus—Doxorubicin—thyroid cancer	0.000182	0.00032	CcSEcCtD
Paliperidone—Vomiting—Epirubicin—thyroid cancer	0.000177	0.000311	CcSEcCtD
Paliperidone—Diarrhoea—Doxorubicin—thyroid cancer	0.000176	0.00031	CcSEcCtD
Paliperidone—Rash—Epirubicin—thyroid cancer	0.000176	0.000309	CcSEcCtD
Paliperidone—Dermatitis—Epirubicin—thyroid cancer	0.000175	0.000308	CcSEcCtD
Paliperidone—Headache—Epirubicin—thyroid cancer	0.000175	0.000307	CcSEcCtD
Paliperidone—Dizziness—Doxorubicin—thyroid cancer	0.00017	0.000299	CcSEcCtD
Paliperidone—Nausea—Epirubicin—thyroid cancer	0.000165	0.000291	CcSEcCtD
Paliperidone—Vomiting—Doxorubicin—thyroid cancer	0.000164	0.000288	CcSEcCtD
Paliperidone—Rash—Doxorubicin—thyroid cancer	0.000163	0.000285	CcSEcCtD
Paliperidone—Dermatitis—Doxorubicin—thyroid cancer	0.000162	0.000285	CcSEcCtD
Paliperidone—Headache—Doxorubicin—thyroid cancer	0.000161	0.000284	CcSEcCtD
Paliperidone—Nausea—Doxorubicin—thyroid cancer	0.000153	0.000269	CcSEcCtD
Paliperidone—ADRA1B—Signaling Pathways—NRG1—thyroid cancer	2.34e-05	0.000331	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—BRAF—thyroid cancer	2.29e-05	0.000325	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—HRAS—thyroid cancer	2.29e-05	0.000325	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TERT—thyroid cancer	2.28e-05	0.000324	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—BRAF—thyroid cancer	2.25e-05	0.00032	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TERT—thyroid cancer	2.2e-05	0.000312	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TERT—thyroid cancer	2.19e-05	0.000311	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—KRAS—thyroid cancer	2.19e-05	0.00031	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—HIF1A—thyroid cancer	2.18e-05	0.00031	CbGpPWpGaD
Paliperidone—ADRA2B—Hemostasis—AKT1—thyroid cancer	2.16e-05	0.000307	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—NRAS—thyroid cancer	2.16e-05	0.000306	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NRG1—thyroid cancer	2.15e-05	0.000306	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—KRAS—thyroid cancer	2.14e-05	0.000304	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TERT—thyroid cancer	2.13e-05	0.000302	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—NRAS—thyroid cancer	2.13e-05	0.000302	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NRG1—thyroid cancer	2.12e-05	0.000301	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NRG1—thyroid cancer	2.11e-05	0.0003	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	2.11e-05	0.000299	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TERT—thyroid cancer	2.1e-05	0.000298	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—KRAS—thyroid cancer	2.1e-05	0.000297	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—HIF1A—thyroid cancer	2.1e-05	0.000297	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NRG1—thyroid cancer	2.07e-05	0.000294	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PPARG—thyroid cancer	2.07e-05	0.000294	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.07e-05	0.000293	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—KRAS—thyroid cancer	2.06e-05	0.000293	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—HIF1A—thyroid cancer	2.04e-05	0.000289	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—BRAF—thyroid cancer	2.03e-05	0.000288	CbGpPWpGaD
Paliperidone—ADRA2C—Hemostasis—AKT1—thyroid cancer	2.02e-05	0.000287	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—HIF1A—thyroid cancer	2.01e-05	0.000285	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—BRAF—thyroid cancer	2e-05	0.000284	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—TP53—thyroid cancer	1.94e-05	0.000276	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TERT—thyroid cancer	1.93e-05	0.000274	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NRG1—thyroid cancer	1.93e-05	0.000273	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—NRAS—thyroid cancer	1.92e-05	0.000273	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TERT—thyroid cancer	1.9e-05	0.00027	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TERT—thyroid cancer	1.9e-05	0.000269	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TERT—thyroid cancer	1.86e-05	0.000264	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—HRAS—thyroid cancer	1.86e-05	0.000264	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—KRAS—thyroid cancer	1.86e-05	0.000263	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	1.86e-05	0.000263	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—HIF1A—thyroid cancer	1.85e-05	0.000262	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—NRAS—thyroid cancer	1.85e-05	0.000262	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—KRAS—thyroid cancer	1.83e-05	0.00026	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—HRAS—thyroid cancer	1.82e-05	0.000258	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—HIF1A—thyroid cancer	1.82e-05	0.000258	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—HIF1A—thyroid cancer	1.82e-05	0.000258	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—BRAF—thyroid cancer	1.81e-05	0.000256	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—TPR—thyroid cancer	1.81e-05	0.000256	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—NRAS—thyroid cancer	1.8e-05	0.000255	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—HRAS—thyroid cancer	1.78e-05	0.000253	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—HIF1A—thyroid cancer	1.78e-05	0.000253	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.78e-05	0.000252	CbGpPWpGaD
Paliperidone—HTR1D—GPCR downstream signaling—AKT1—thyroid cancer	1.77e-05	0.000251	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—NRAS—thyroid cancer	1.77e-05	0.000251	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—HRAS—thyroid cancer	1.75e-05	0.000249	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.74e-05	0.000247	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—RXRA—thyroid cancer	1.74e-05	0.000246	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—BRAF—thyroid cancer	1.74e-05	0.000246	CbGpPWpGaD
Paliperidone—HTR1B—GPCR downstream signaling—AKT1—thyroid cancer	1.73e-05	0.000246	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TERT—thyroid cancer	1.73e-05	0.000246	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CCND1—thyroid cancer	1.71e-05	0.000242	CbGpPWpGaD
Paliperidone—DRD4—GPCR downstream signaling—AKT1—thyroid cancer	1.71e-05	0.000242	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—BRAF—thyroid cancer	1.69e-05	0.000239	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PPARG—thyroid cancer	1.68e-05	0.000239	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CCND1—thyroid cancer	1.67e-05	0.000237	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	1.66e-05	0.000236	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—HIF1A—thyroid cancer	1.66e-05	0.000235	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—KRAS—thyroid cancer	1.65e-05	0.000235	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—PTEN—thyroid cancer	1.65e-05	0.000234	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CCND1—thyroid cancer	1.64e-05	0.000233	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—AKT1—thyroid cancer	1.64e-05	0.000233	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PTGS2—thyroid cancer	1.63e-05	0.000231	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.63e-05	0.000231	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—PTEN—thyroid cancer	1.61e-05	0.000229	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—AKT1—thyroid cancer	1.61e-05	0.000228	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—NRAS—thyroid cancer	1.6e-05	0.000227	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—NRAS—thyroid cancer	1.6e-05	0.000227	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.6e-05	0.000227	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—KRAS—thyroid cancer	1.59e-05	0.000225	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—PTEN—thyroid cancer	1.59e-05	0.000225	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—HRAS—thyroid cancer	1.58e-05	0.000224	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—AKT1—thyroid cancer	1.57e-05	0.000223	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	1.57e-05	0.000223	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—HRAS—thyroid cancer	1.56e-05	0.000221	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—AKT1—thyroid cancer	1.55e-05	0.00022	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—KRAS—thyroid cancer	1.55e-05	0.000219	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PPARG—thyroid cancer	1.54e-05	0.000219	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—AKT1—thyroid cancer	1.53e-05	0.000218	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.53e-05	0.000217	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	1.52e-05	0.000216	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—AKT1—thyroid cancer	1.51e-05	0.000215	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—BRAF—thyroid cancer	1.51e-05	0.000214	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—BRAF—thyroid cancer	1.5e-05	0.000213	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCND1—thyroid cancer	1.48e-05	0.00021	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	1.48e-05	0.000209	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—NRAS—thyroid cancer	1.47e-05	0.000208	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCND1—thyroid cancer	1.46e-05	0.000207	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—NRAS—thyroid cancer	1.46e-05	0.000207	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—NRAS—thyroid cancer	1.44e-05	0.000204	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—PTEN—thyroid cancer	1.43e-05	0.000203	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PTEN—thyroid cancer	1.42e-05	0.000202	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—NRAS—thyroid cancer	1.42e-05	0.000201	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—PTEN—thyroid cancer	1.41e-05	0.0002	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—HRAS—thyroid cancer	1.41e-05	0.000199	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.4e-05	0.000199	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—AKT1—thyroid cancer	1.39e-05	0.000198	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—KRAS—thyroid cancer	1.38e-05	0.000196	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—KRAS—thyroid cancer	1.38e-05	0.000195	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—AKT1—thyroid cancer	1.38e-05	0.000195	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—BRAF—thyroid cancer	1.37e-05	0.000194	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—AKT1—thyroid cancer	1.37e-05	0.000194	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	1.36e-05	0.000193	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.35e-05	0.000192	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	1.35e-05	0.000192	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—HRAS—thyroid cancer	1.35e-05	0.000192	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—thyroid cancer	1.32e-05	0.000188	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	1.32e-05	0.000187	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCND1—thyroid cancer	1.32e-05	0.000187	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—HRAS—thyroid cancer	1.31e-05	0.000186	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—AKT1—thyroid cancer	1.31e-05	0.000186	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	1.29e-05	0.000183	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—AKT1—thyroid cancer	1.28e-05	0.000181	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NRAS—thyroid cancer	1.27e-05	0.000181	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCND1—thyroid cancer	1.27e-05	0.000181	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—PTEN—thyroid cancer	1.27e-05	0.000181	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCND1—thyroid cancer	1.27e-05	0.00018	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—KRAS—thyroid cancer	1.26e-05	0.000179	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NRAS—thyroid cancer	1.26e-05	0.000178	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	1.26e-05	0.000178	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—KRAS—thyroid cancer	1.26e-05	0.000178	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—AKT1—thyroid cancer	1.24e-05	0.000176	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—KRAS—thyroid cancer	1.24e-05	0.000176	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCND1—thyroid cancer	1.23e-05	0.000175	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—PTEN—thyroid cancer	1.23e-05	0.000174	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—PTEN—thyroid cancer	1.22e-05	0.000173	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—KRAS—thyroid cancer	1.22e-05	0.000173	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.21e-05	0.000172	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	1.21e-05	0.000172	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	1.2e-05	0.00017	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—AKT1—thyroid cancer	1.19e-05	0.000169	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—HRAS—thyroid cancer	1.19e-05	0.000169	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—PTEN—thyroid cancer	1.19e-05	0.000169	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—HRAS—thyroid cancer	1.17e-05	0.000166	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—HRAS—thyroid cancer	1.17e-05	0.000166	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	1.17e-05	0.000166	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—AKT1—thyroid cancer	1.16e-05	0.000165	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	1.16e-05	0.000164	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTEN—thyroid cancer	1.15e-05	0.000164	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	1.15e-05	0.000163	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	1.14e-05	0.000162	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—AKT1—thyroid cancer	1.14e-05	0.000162	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—AKT1—thyroid cancer	1.14e-05	0.000161	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—RXRA—thyroid cancer	1.14e-05	0.000161	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NRAS—thyroid cancer	1.14e-05	0.000161	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TP53—thyroid cancer	1.12e-05	0.000159	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCND1—thyroid cancer	1.12e-05	0.000159	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	1.12e-05	0.000158	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TP53—thyroid cancer	1.1e-05	0.000156	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCND1—thyroid cancer	1.1e-05	0.000156	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCND1—thyroid cancer	1.1e-05	0.000156	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—KRAS—thyroid cancer	1.1e-05	0.000156	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARG—thyroid cancer	1.1e-05	0.000156	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NRAS—thyroid cancer	1.1e-05	0.000155	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NRAS—thyroid cancer	1.09e-05	0.000155	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TP53—thyroid cancer	1.08e-05	0.000154	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—KRAS—thyroid cancer	1.08e-05	0.000154	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—PTEN—thyroid cancer	1.08e-05	0.000153	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	1.08e-05	0.000153	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—HRAS—thyroid cancer	1.08e-05	0.000153	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—HRAS—thyroid cancer	1.07e-05	0.000151	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—PTEN—thyroid cancer	1.06e-05	0.000151	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NRAS—thyroid cancer	1.06e-05	0.00015	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—PTEN—thyroid cancer	1.06e-05	0.00015	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTEN—thyroid cancer	1.06e-05	0.00015	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—HRAS—thyroid cancer	1.05e-05	0.000149	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—AKT1—thyroid cancer	1.05e-05	0.000149	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	1.04e-05	0.000148	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	1.04e-05	0.000147	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.04e-05	0.000147	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—HRAS—thyroid cancer	1.04e-05	0.000147	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—AKT1—thyroid cancer	1.04e-05	0.000147	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—AKT1—thyroid cancer	1.03e-05	0.000147	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	1.01e-05	0.000144	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCND1—thyroid cancer	1e-05	0.000142	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—KRAS—thyroid cancer	9.77e-06	0.000139	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TP53—thyroid cancer	9.75e-06	0.000138	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—PTEN—thyroid cancer	9.66e-06	0.000137	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NRAS—thyroid cancer	9.62e-06	0.000137	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TP53—thyroid cancer	9.62e-06	0.000136	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—AKT1—thyroid cancer	9.49e-06	0.000135	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NRAS—thyroid cancer	9.47e-06	0.000134	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NRAS—thyroid cancer	9.45e-06	0.000134	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—KRAS—thyroid cancer	9.43e-06	0.000134	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—AKT1—thyroid cancer	9.42e-06	0.000134	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—KRAS—thyroid cancer	9.39e-06	0.000133	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—HRAS—thyroid cancer	9.33e-06	0.000132	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—AKT1—thyroid cancer	9.3e-06	0.000132	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	9.27e-06	0.000132	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—HRAS—thyroid cancer	9.2e-06	0.000131	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—AKT1—thyroid cancer	9.15e-06	0.00013	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—KRAS—thyroid cancer	9.13e-06	0.000129	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	8.98e-06	0.000127	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TP53—thyroid cancer	8.69e-06	0.000123	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—thyroid cancer	8.63e-06	0.000122	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NRAS—thyroid cancer	8.62e-06	0.000122	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TP53—thyroid cancer	8.39e-06	0.000119	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TP53—thyroid cancer	8.34e-06	0.000118	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—HRAS—thyroid cancer	8.31e-06	0.000118	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—KRAS—thyroid cancer	8.28e-06	0.000118	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—AKT1—thyroid cancer	8.23e-06	0.000117	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—AKT1—thyroid cancer	8.19e-06	0.000116	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—KRAS—thyroid cancer	8.15e-06	0.000116	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—KRAS—thyroid cancer	8.13e-06	0.000115	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—AKT1—thyroid cancer	8.12e-06	0.000115	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TP53—thyroid cancer	8.11e-06	0.000115	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—HRAS—thyroid cancer	8.02e-06	0.000114	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TP53—thyroid cancer	7.99e-06	0.000113	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	7.98e-06	0.000113	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—HRAS—thyroid cancer	7.98e-06	0.000113	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—HRAS—thyroid cancer	7.76e-06	0.00011	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	7.64e-06	0.000108	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTEN—thyroid cancer	7.53e-06	0.000107	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—KRAS—thyroid cancer	7.42e-06	0.000105	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TP53—thyroid cancer	7.36e-06	0.000104	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—AKT1—thyroid cancer	7.34e-06	0.000104	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TP53—thyroid cancer	7.24e-06	0.000103	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TP53—thyroid cancer	7.23e-06	0.000103	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARG—thyroid cancer	7.17e-06	0.000102	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TP53—thyroid cancer	7.09e-06	0.000101	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—AKT1—thyroid cancer	7.08e-06	0.0001	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—AKT1—thyroid cancer	7.04e-06	9.99e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—HRAS—thyroid cancer	7.04e-06	9.99e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—HRAS—thyroid cancer	6.93e-06	9.83e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—HRAS—thyroid cancer	6.91e-06	9.81e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—AKT1—thyroid cancer	6.85e-06	9.72e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	6.78e-06	9.62e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	6.74e-06	9.57e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—AKT1—thyroid cancer	6.66e-06	9.44e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TP53—thyroid cancer	6.59e-06	9.35e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—HRAS—thyroid cancer	6.3e-06	8.94e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AKT1—thyroid cancer	6.22e-06	8.82e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AKT1—thyroid cancer	6.12e-06	8.68e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AKT1—thyroid cancer	6.1e-06	8.66e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—AKT1—thyroid cancer	6.1e-06	8.65e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	5.99e-06	8.5e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.64e-06	8e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AKT1—thyroid cancer	5.57e-06	7.89e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTEN—thyroid cancer	4.92e-06	6.98e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AKT1—thyroid cancer	4.34e-06	6.15e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AKT1—thyroid cancer	2.84e-06	4.02e-05	CbGpPWpGaD
